Polar Asset Management Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,400
Closed -$1.87M 751
2025
Q2
$1.87M Buy
+2,400
New +$1.86M 0.03% 317
2024
Q3
Sell
-2,500
Closed -$2.26M 776
2024
Q2
$2.26M Buy
2,500
+1,800
+257% +$1.44M 0.05% 305
2024
Q1
$545K Buy
+700
New +$498K 0.01% 460
2023
Q4
Sell
-2,300
Closed -$1.24M 863
2023
Q3
$1.24M Sell
2,300
-16,200
-88% -$8.35M 0.03% 435
2023
Q2
$8.68M Sell
18,500
-3,400
-16% -$1.43M 0.16% 167
2023
Q1
$7.52M Sell
21,900
-10,900
-33% -$3.68M 0.11% 245
2022
Q4
$12M Hold
32,800
0.15% 185
2022
Q3
$10.6M Hold
32,800
0.13% 241
2022
Q2
$10.6M Buy
+32,800
New +$9.85M 0.12% 246
2021
Q2
Sell
-1,229
Closed -$230K 1217
2021
Q1
$230K Buy
+1,229
New +$240K ﹤0.01% 761

Other funds holding LLY

Polar Asset Management Partners's LLY Position: Q3 2025 in Review

Polar Asset Management Partners sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 2,400 shares — an estimated $1.87M sold.

Polar Asset Management Partners first reported a position in LLY in Q1 2021 and held it in 10 quarters. The position peaked at $12M in Q4 2022. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Polar Asset Management Partners reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • Polar Asset Management Partners sold 2,400 Eli Lilly shares in Q3 2025, an estimated $1.87M.
  • Polar Asset Management Partners first reported a position in Eli Lilly in Q1 2021 and held it in 10 quarters.
  • Polar Asset Management Partners's Eli Lilly position peaked at $12M in Q4 2022.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Polar Asset Management Partners's 13F filing for Q3 2025, filed 14 Nov 2025.